Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Low level exposure to inorganic mercury interferes with B cell receptor signaling in transitional type 1 B cells

Journal Article · · Toxicology and Applied Pharmacology
 [1];  [2]
  1. Department of Immunology, Microbiology and Biochemistry, Wayne State University, Detroit, MI (United States)
  2. Department of Environmental Medicine, University of Rochester, Rochester, NY (United States)

Mercury (Hg) has been implicated as a factor contributing to autoimmune disease in animal models and humans. However the mechanism by which this occurs has remained elusive. Since the discovery of B cells it has been appreciated by immunologists that during the normal course of B cell development, some immature B cells must be generated that produce immunoglobulin reactive to self-antigens (auto-antibodies). However in the course of normal development, the vast majority of immature auto-reactive B cells are prevented from maturing by processes collectively known as tolerance. Autoimmune disease arises when these mechanisms of tolerance are disrupted. In the B cell compartment, it is firmly established that tolerance depends in part upon negative selection of self-reactive immature (transitional type 1) B cells. In these cells negative selection depends upon signals generated by the B Cell Receptor (BCR), in the sense that those T1 B cells who's BCRs most strongly bind to, and so generate the strongest signals to self-antigens are neutralized. In this report we have utilized multicolor phosphoflow cytometry to show that in immature T1 B cells Hg attenuates signal generation by the BCR through mechanisms that may involve Lyn, a key tyrosine kinase in the BCR signal transduction pathway. We suggest that exposure to low, environmentally relevant levels of Hg, disrupts tolerance by interfering with BCR signaling in immature B cells, potentially leading to the appearance of mature auto-reactive B cells which have the ability to contribute to auto-immune disease. - Highlights: • Hg{sup 2+} interferes with BCR-mediated activation of ERK in immature T1 B cells. • Hg{sup 2+} acts upstream of ERK. • BCR mediated activation of Syk and the CD79a ITAM are attenuated in immature T1 B cells by Hg{sup 2+}. • The mechanism whereby which Hg{sup 2+} affects Syk and CD7a activation involves the tyrosine phosphokinase Lyn.

OSTI ID:
22722910
Journal Information:
Toxicology and Applied Pharmacology, Journal Name: Toxicology and Applied Pharmacology Vol. 330; ISSN TXAPA9; ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

A systems toxicology approach identifies Lyn as a key signaling phosphoprotein modulated by mercury in a B lymphocyte cell model
Journal Article · Tue Apr 01 00:00:00 EDT 2014 · Toxicology and Applied Pharmacology · OSTI ID:22439688

Spleen tyrosine kinase mediates high glucose-induced transforming growth factor-{beta}1 up-regulation in proximal tubular epithelial cells
Journal Article · Mon Sep 10 00:00:00 EDT 2012 · Experimental Cell Research · OSTI ID:22212595

Ikaros limits follicular B cell activation by regulating B cell receptor signaling pathways
Journal Article · Thu Feb 11 23:00:00 EST 2016 · Biochemical and Biophysical Research Communications · OSTI ID:22594244